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Recombinant fusion protein technology allows speciﬁc insecticidal protein and peptide toxins to display
activity in orally-delivered biopesticides. The spider venom peptide d-amaurobitoxin-PI1a, which targets
insect voltage-gated sodium channels, was fused to the “carrier” snowdrop lectin (GNA) to confer oral
toxicity.
The toxin itself (PI1a) and an amaurobitoxin/GNA fusion protein (PI1a/GNA) were produced using the
yeast Pichia pastoris as expression host. Although both proteins caused mortality when injected into
cabbage moth (Mamestra brassicae) larvae, the PI1a/GNA fusion was approximately 6 times as effective as
recombinant PI1a on a molar basis. PI1a alone was not orally active against cabbage moth larvae, but a
single 30 mg dose of the PI1a/GNA fusion protein caused 100% larval mortality within 6 days when fed to
3rd instar larvae, and caused signiﬁcant reductions in survival, growth and feeding in 4th e 6th instar
larvae. Transport of fusion protein from gut contents to the haemolymph of cabbage moth larvae, and
binding to the nerve chord, was shown by Western blotting. The PI1a/GNA fusion protein also caused
mortality when delivered orally to dipteran (Musca domestica; houseﬂy) and hemipteran (Acyrthosiphon
pisum; pea aphid) insects, making it a promising candidate for development as a biopesticide.
 2014 The Authors. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction be used to produce recombinant proteins with insecticidal activity.Synthetic pesticides have been widely used for crop protection
against herbivorous insects in intensive agricultural production,
and are a necessary input to achieve high yields and consequent
food security. However, there are widely held concerns over the
indiscriminate use of pesticides in general, and insecticides in
particular, including the development of resistance in target pests,
detrimental effects in non-pest and beneﬁcial insects, contamina-
tion of watercourses and the poisoning of higher animals. There-
fore, many of the older, broad-spectrum insecticidal compounds
have been, or are likely to be, withdrawn (Denholm and Rowland,
1992; Casida and Quistad, 1998; Desneux et al., 2007). Protein-
based biopesticides fulﬁl many of the criteria required for more
environmentally compatible approaches to pest control, since they
combine efﬁcacy with speciﬁcity, and are biodegradable in the
environment. Besides naturally occurring protein biopesticides
such as Bacillus thuringiensis toxins, biotechnological methods canx: þ44 191 334 1201.
Gatehouse).
r Ltd. Open access under CC BY license.These include insecticidal fusion proteins containing a toxic peptide
or protein fused to a “carrier”, where the carrier confers oral activity
on a toxin that must normally be injected into the insect to reach its
site of action, by directing transport of the fusion across the insect
gut (Fitches et al., 2004).
Venoms isolated from a range of arachnids have been shown to
contain proteins which are biologically active toxins when injected
intopotential prey.Mostare small proteins, in the range30e70amino
acid residues (variously referred to as peptides or proteins), that
principally target neuronal ion channels, and to a lesser extent
neuronal receptors and presynaptic membrane proteins, to cause
paralysis of the prey (Rash and Hodgson, 2002). As a result of evolu-
tionary selection, some toxins combine ahigh toxicity for insectswith
no effects on members of other taxons (Vassilevski et al., 2009). The
potency and selective mode of action of spider neurotoxins would
make them ideal candidates for use in environmentally compatible
pestmanagement technologies, if a suitable delivery system could be
devised (Whetstone and Hammock, 2007). In general, these toxins
are not effective as oral or contact insecticides, and no systemwhich
requires injection could possibly be feasible in the ﬁeld.
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generally function via oral delivery, with the toxin proteins present
in, or sprayed on plant tissues susceptible to damage. The use of a
“carrier” in recombinant fusion proteins leads to transport of toxin
proteins from the gut contents across the insect gut epithelium to
the central nervous system where the toxin is active, resulting in
dramatically enhanced oral insecticidal activity (Fitches et al.,
2002). The mannose-speciﬁc lectin from snowdrop (Galanthus
nivalis agglutinin: GNA) has proved successful as a carrier. It is
resistant to proteolytic activity in the insect gut, and can bind to gut
epithelial glycoproteins, leading to transport into the haemolymph
following ingestion. For example, a toxin protein from the spider
Segestria ﬂorentina was delivered to the haemolymph of lepidop-
teran larvae after oral delivery by fusing to GNA, causing decreased
survival and growth in insects fed on diet containing the fusion
protein (Fitches et al., 2004). Fusion proteins are required to possess
good stability, so they cannot be degraded in the environment or
digested by gut enzymes of pests, and high toxicity, with activity
towards pests comparable to the toxin proteins themselves.
d-Amaurobitoxins, or d-palutoxins, from the spider Pireneitega
luctuosus (Araneae: Amaurobiidae; previously referred to as Para-
coelotes luctuosus) are a family of four similar 36e37 residue pep-
tides, designated Pl1a-d (Corzo et al., 2000). They contain 8 cysteine
residues, which are disulphide-linked to form a cysteine knotmotif.
The d-amaurobitoxins are effective insecticides, with an estimated
LD50 values of 0.95e4.48 mg/100 mg when injected into lepidop-
teran larvae (oriental leafworm moth; Spodoptera litura). They
show insect-speciﬁc toxicity, with no effects observed for Pl1a, Pl1c
and Pl1d after intravenal injection in mice. The amaurobitoxins
speciﬁcally target insect sodium channels, and their solution
structure has elucidated the nature of the interaction (Corzo et al.,
2005; Ferrat et al., 2005). The toxin Pl1a was selected as the subject
of this study as it combines the highest insecticidal activity with no
observed toxicity towards higher animals, and thus would be
suitable as a biopesticide.
The present paper reports the production, puriﬁcation and
biological activity of recombinant d-amaurobitoxin PI1a, and the
fusion protein PI1a/GNA comprised of PI1a linked to the N-termi-
nus of GNA. It shows that fusion to GNA enhances the insecticidal
activity of Pl1a. Not only was fusion protein more toxic than re-
combinant PI1a when injected into cabbage moth (Mamestra
brassicae) larvae, but it also had effective oral toxicity when the
toxin alone did not. The fusion protein was also orally toxic to in-
sects of different orders, pea aphids (Acyrthosiphon pisum; Hemi-
ptera) and houseﬂy (Musca domestica; Diptera). The PI1a/GNA
fusion protein has potential to be a useful biopesticide for crop
protection in the future.2. Materials and methods
2.1. Materials
Chemicals and reagents were of analytical grade and were
supplied by Sigma or BDH Chemical Company otherwise unless
stated. Restriction enzymes and other molecular biology reagents
were supplied by Fermentas. A double stranded DNA incorporating
a sequence encoding the mature PI1a toxin (P83256), with codon
usage optimised for yeast, was designed by the authors, syn-
thesised and supplied by ShineGene Molecular Biotech, Inc.
(Shanghai 201109, China; http://www.synthesisgene.com/) in the
vector pUC57. Other oligonucleotides were supplied by Sigma
Chemical Co. Recombinant snowdrop lectin was produced by the
authors by expression in Pichia pastoris, as described by
Baumgartner et al. (2004).Mamestra brassicae (cabbage moth) were maintained in a li-
cenced growth facility. The cultures were subject to a 16 h light, 8 h
dark cycle and maintained at 25 C, 40% relative humidity on a
standard lepidopteran diet as described before (Bown et al., 1997).
M. domestica (houseﬂy) larvae were maintained on a wheat ﬂour
diet under similar conditions; adults were given 10% sucrose so-
lution ad libitum. A. pisum (pea aphid) was cultured on plants of
Vicia faba (broad bean cv. Sutton Dwarf) under conditions of 12 h
light, 12 h dark, 18 C, 70% relative humidity.
2.2. Expression constructs
The Pl1a coding sequence was transferred from pUC57 to the
yeast expression vector pGAPZaB (Invitrogen; www.invitrogen.
com) by digestion with PstI and XbaI, isolation of the coding
sequence fragment by agarose gel electrophoresis, followed by
ligation to pGAPZaB which had been restricted with the same en-
zymes. DNA fragments were separated by agarose gel electropho-
resis prior to ligation, and were puriﬁed from excised gel slices
using a QuiaQuick Gel Extraction Kit (Qiagen; www.qiagen.com) as
described in the manufacturer’s protocol. After ligation, the
resulting recombinant plasmid was cloned using standard pro-
tocols by transformation of electro-competent cells of E. coli
(Sambrook and Russell, 2001). Selected clones were checked for
correct assembly of the construct by DNA sequencing.
To produce a construct encoding the Pl1a/GNA fusion protein,
the mature PI1a coding sequence from a veriﬁed expression
construct in pGAPZaB was excised by digestion with PstI and NotI,
and puriﬁed by agarose gel electrophoresis as described above. A
pGAPZaB plasmid containing the fusion protein construct Hv1a/
GNA (Fitches et al., 2012) was digested with PstI and NotI to remove
the Hv1a coding sequence, and puriﬁed by agarose gel electro-
phoresis. The Hv1a coding sequence was then replaced by Pl1a by
ligating the puriﬁed fragments, and cloning the resulting recom-
binant plasmid. Selected clones containing the expression vector
encoding the PI1a/GNA fusion protein were veriﬁed by DNA
sequencing. All DNA sequencing was carried out using Applied
Biosystems ABI Prism 3730 automated DNA sequencers by DBS
Genomics, School of Biological and Biomedical Sciences, Durham
University, UK.
2.3. Expression of PI1a and PI1A/GNA fusion proteins in yeast
pGAPZa plasmids containing the PI1a and PI1a/GNA expression
constructs were ampliﬁed in E. coli, puriﬁed and linearized with
BlnI. Linearised plasmids were transformed into Pichia pastoris
strain SMD1168H (Invitrogen) using the EasyComp Transformation
kit (Invitrogen) as described in the manufacturer’s protocol.
Transformed yeast clones were plated and selected on YPG agar
plates (1% yeast extract (w/v), 2% peptone (w/v), 4% glycerol (v/v),
1.5% agar (w/v)) containing zeocin (100 mg/ml). Selected clones (at
least 10 for each construct) were checked for expression of re-
combinant proteins by analysis of culture supernatant from small-
scale shake ﬂask cultures grown for 2e3 days in YPGezeocin media
at 30 C. Samples of supernatant were separated by SDS-
polyacrylamide gel electrophoresis; gels were blotted onto nitro-
cellulose and probed with anti-(His)6 primary antibodies (Bio-Rad)
or anti-GNA primary antibodies, followed bywashing, probing with
HRP-conjugated secondary antibodies (Bio-Rad), and detection of
bound antibodies by ECL, as described previously (Fitches and
Gatehouse, 1998).
Selected clones of P. pastoris containing the integrated PI1a and
PI1a/GNA constructs were grown in a 7.5 L BioFlo 110 bench-top
fermenter (New Brunswick Scientiﬁc). For fermentation, two
100 ml YPG cultures of P. pastoris containing toxin or fusion genes
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to inoculate 2.5 L of sterile minimal media supplemented with
PTM1 salts. Cultivation at 30 C, 30% dissolved oxygen; pH 4.5 with
continuous agitation was continued with a glycerol feed (5e10 ml/
h) over a period of 4 days (Fitches et al., 2004). Culture supernatant
was separated from cells by centrifugation (20 min at 5000 g),
ﬁltered through GF/D and GF/F glass ﬁbre membranes (Whatman)
and adjusted to 0.02 M sodium phosphate buffer, 0.4 M sodium
chloride, pH 7.4 by adding 4 concentrated stock.
Recombinant proteins were puriﬁed from clariﬁed culture su-
pernatant by nickel afﬁnity chromatography on 5 ml HisTrap crude
nickel columns (GE Healthcare) with a ﬂow rate of 2 ml/min. After
loading, the columns were washed with 0.02 M sodium phosphate
buffer, 0.4 M sodium chloride pH 7.4 and the bound proteins were
eluted with 0.2 M imidazole in the same buffer. Eluted proteins
were checked for purity by SDS-PAGE, dialysed against deionised
water using multiple changes to remove all small molecules, and
freeze-dried.
2.4. Protein characterisation
Amounts of recombinant proteins were quantitatively estimated
by comparison to known amounts of GNA standards run on SDS-
PAGE gels, or by BCA analysis using a BCA Protein Assay Kit
(Thermo Scientiﬁc). For N-terminal sequencing, proteins were
separated by SDS-PAGE and blotted onto PVDF membrane. Excised
bands were supplied for N-terminal sequencing to a commercial
protein sequencing service (Shanghai Applied Protein Technology
Co., Ltd, China). For further characterisation, recombinant PI1a and
PI1a/GNA fusion protein were denatured by dissolving in 6 M urea
and incubating at room temperature for 15 min prior to addition of
SDS-sample buffer, and analysis by SDS-PAGE.
The presence of N-linked glycosylation on recombinant proteins
was shown by treatment with PNGase F, using a deglycosylation kit
from Biolabs Co., Ltd, UK as described in the manufacturer’s pro-
tocol. 1 ml Glycoprotein Denaturing Buffer was added to 6 mg protein
(dissolved in 5 ml 1 PBS), and the mixture was incubated 10 min at
100 C. After cooling, 2 ml 10G7 Reaction Buffer, 2 ml 10% NP40 and
1.5 ml PNGase F were added to a ﬁnal volume of 20 ml, and the
mixture was incubated at 37 C for 1 h. The proteins were then
analysed by SDS-PAGE. A reaction in which PNGase was omitted
was used as a control.
2.5. Bioassays on cabbage moth larvae
Injection bioassays were carried out using 4e5th stadium
M. brassicae larvae (approx.45e55mg inweight) by injecting 5 ml of
aqueous solution containing varying doses of PI1a and PI1A/GNA
dissolved in1PBS (phosphatebuffered saline; 0.15MNaCl, 0.015M
sodium-phosphate buffer, pH 7.2). Controls were injected with 5 ml
1 PBS. For each dose, 30 larvae were injected and paralysis and
mortality were scored at 12, 24, 36, 48, 60 and 72 h post injection
including control. To estimate LD50 values, mortality at 48 h was
used, to make results comparable to those of Corzo et al. (2000).
Droplet-feeding assays were conducted to assess the oral ac-
tivity of PI1A/GNA towards M. brassicae third to sixth instar larvae.
Larvae were fed once with a 2 ml droplet containing 20 or 30 mg of
PI1A/GNA, 30 mg of PI1a, or 30 mg of GNA in 1 PBS and 10% sucrose.
Smaller larvae had exposed repeatedly until they ﬁnished the 2 ml
droplet. Control larvae were fed on droplets containing 1 PBS and
10% sucrose solution. Treated larvae were placed in ventilated
plastic pots (250 ml) with standard artiﬁcial diet after consumption
of the droplet. To encourage droplet consumption, larvae were
starved for approx. 24 h prior to feeding. Larval weight and survival
was recorded daily after droplet feeding. In experiments todetermine effect on feeding, the artiﬁcial diet was weighed prior to
introduction, and re-weighed on removal to determine the amount
consumed; diet was replaced daily.
To study fusion protein uptake into insects, ﬁfth instar larvae
were droplet-fed with a sub-lethal dose (20 mg) of Pl1a/GNA fusion
protein as described above, and then transferred back to standard
rearing diet, to give a “feed-chase” experiment. Haemolymph sam-
ples were extracted from M. brassicae larvae at different intervals
(2e72 h) after feeding as described previously (Fitches et al., 2012),
and the extracted haemolymph was quantiﬁed for protein content
(BCA Protein Assay Kit, Pierce; www.piercenet.com). Tissues
(midgut, Malpighian tubules, fat body, nerve chord) were dissected
from selected larvae, and extracted as described previously (Fitches
et al., 2012). Western blotting of larval haemolymph and tissue
samples was carried out using anti-GNA antibodies (1:3300 dilu-
tion) as described previously (Fitches et al., 2001). Similar methods
wereused to follow the fate of Pl1a/GNA fusionprotein (20 mgdoses)
injected into the haemolymph of 5th instarM. brassicae larvae.
2.6. Bioassays on houseﬂies
Adults of M. domestica were injected with 1.0 ml of aqueous
solution containing varying doses of PI1a and PI1a/GNA dissolved
in 1 PBS, using a conventional Hamilton syringe with a ﬁne
needle. Survival was monitored over a 144 h period. In feeding
assays, adult ﬂies were allowed to feed from cotton pads which had
been soaked in a solution containing varying concentrations of
Pl1a/GNA in 60% sucrose; survival was monitored over a 120 h
period in which ﬂies were exposed continuously to the treatment.
2.7. Bioassays on pea aphids
The toxicity of proteins to A. pisumwas determined by bioassay
using a liquid artiﬁcial diet (Prosser and Douglas, 1992), using a
paraﬁlm sachet to deliver diet to insects. Proteins were dissolved in
sterile diet at known concentrations. The standard assay used 1e2
day-old aphid nymphs, which had been conditioned by transfer to
diet without added proteins prior to receiving the protein treat-
ments, and continued the assay until the insects became mature.
For experiments to investigate retention of proteins in aphids, PI1a/
GNA, PI1a and GNA were labelled with ﬂuorescein isothiocyanate
(FITC) by mixing together equimolar concentrations of FITC (solu-
tion in dimethyl sulphoxide) and PI1a/GNA, PI1a and GNA (solu-
tions in 1 PBS) (0.02 mg of FITC/mg of PI1a/GNA, 0.04 mg of FITC/
mg of PI1a and 0.03 mg of FITC/mg of GNA, respectively). Aphids
were fed on diets containing labelled proteins for 24 h, then
transferred to control diet for a “chase” period of up to 48 h.
Labelled proteins were detected by ﬂuorescence microscopy of
whole insects.
2.8. Statistical analysis
Survival data were analysed using KaplaneMeier survival
analysis, using Prism (v. 5) software. All other data analysis was
carried out using Origin 8.5 graphing and data analysis software.
ANOVA analysis (with BonferronieDunn post-hoc tests) was car-
ried out to determine any signiﬁcant differences between treat-
ments in the parameters measured.
3. Results
3.1. Expression and puriﬁcation of recombinant PI1a and PI1a/GNA
Expression constructs for production of recombinant proteins in
the methylotrophic yeast Pichia pastoris were based on the vector
Fig. 2. Characterisation of puriﬁed recombinant proteins by SDS-PAGE followed by
Coomassie blue staining. (A) Pl1a toxin separated on “normal” SDS-PAGE; M indicates
marker, loadings of Pl1a are 5 and 10 mg (B) Pl1a toxin (5 mg) separated on SDS-PAGE
after denaturation by 6 M urea. (C) Pl1a/GNA fusion protein (10 mg). (D) Deglycosyla-
tion of Pl1a/GNA fusion protein using PNGase F (band indicated by open arrowhead).
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integrates into the yeast genome at the GAPDH locus, giving stable
transformants. The expression construct for production of recom-
binant Pl1a contained a synthetic coding sequence corresponding
to the published amino acid sequence for the toxin, arranged in-
frame C-terminal to a sequence encoding the yeast a-factor
prepro-sequence, and N-terminal to sequences encoding the myc
epitope and (His)6 tag, supplied by the vector (Fig. 1A). The
expression construct for production of recombinant PI1a/GNA
fusion protein contained the same synthetic mature PI1a coding
sequence fused to the N-terminus of a coding sequence corre-
sponding to residues 1e105 of mature snowdrop lectin (GNA) via a
3 amino acid linker peptide; again, the fusion protein was arranged
in-frame C-terminal to the a-factor prepro-sequence, and N-ter-
minal to a sequence encoding the (His)6 tag, supplied by the vector
(Fig. 1B). The constructs were assembled by restriction-ligation and
were checked by DNA sequencing after cloning.
Veriﬁed clones of expression constructs were transformed into
the protease-deﬁcient P. pastoris strain SMD1168H, using antibiotic
(zeocin) selection for transformants. Approx. 50 resistant colonies
were obtained for each expression construct. Culture supernatant
from selected clones grown in shake-ﬂask cultureswas analysed for
production of recombinant proteins by Western blotting, to allow
selection of clones producing the highest levels of PI1a and PI1a/
GNA. Screening of large numbers of transformed yeast clones was
not necessary, since most clones were expressing recombinant
proteins, as judged by the presence of immunoreactive bands of the
expected size on Western blots of culture supernatants.
For each construct, the best-expressing clone of those screened
in small-scale cultures was selected for large-scale protein pro-
duction by bench top fermentation. Culture supernatants were
puriﬁed by nickel afﬁnity chromatography, and eluted peaks were
desalted by dialysis, and lyophilized. Yields of recombinant proteins
were comparable to other fusion proteins prior to optimisation;
Pl1a was produced at approx. 26 mg/L and PI1A/GNA at approx.
21 mg/L, as estimated by semi-quantitative SDS-PAGE.
Puriﬁed recombinant proteins were analysed by SDS-PAGE and
western blot. The recombinant toxin Pl1a (Fig. 2A) ran as a closely
spaced double band at an indicated mol. wt. of approx. 18 kDa on
normal SDS-PAGE gels; both bands were immunoreactive with
anti-(His)6 antibodies on Western blotting (not presented). The
predictedmol. wt. of recombinant Pl1a, including the tag sequences
is 7.07 kDa. The double band and incorrect mol. wt. of toxin was
reproducible with different gels, samples, and use of reducing
agents prior to electrophoresis, but was considered to be an artefact
of the gel system, possibly as a result of poor binding of SDS to the
polypeptide. When the same samples were treated with 6 M urea
prior to electrophoresis, Pl1a gave a single band at an indicatedmol.Fig. 1. Sequences of predicted products from expression constructs for Pl1a toxin (A) and P
cleavage point for removal of the yeast a-factor prepro-sequence is indicated by an arrow. D
join the Pl1a and GNA coding sequences together.wt. of 14 kDa (Fig. 2B); the shift in mobility is indicative of gel ar-
tefacts, and the single band indicates homogeneity of the product.
Further analysis on urea-containing gels gave single bands for Pl1a,
with indicated mol. wts. of approx. 11 kDa without blocking
cysteine residues, and approx. 9 kDa after treatment withl1a/GNA fusion protein (B). Shaded regions indicate sequence provided by vector; the
otted box in (B) indicates the “linker” sequence contributed by the nucleotides used to
Fig. 3. Bioassays of Pl1a and Pl1a/GNA against larvae of cabbage moth (Mamestra brassicae). (A) Survival of 5th instar larvae after injection of varying amounts of Pl1a toxin. (B)
Survival of 5th instar larvae after injection of varying amounts of Pl1a/GNA fusion protein. (C) Survival of 3rd instar larvae after feeding a single dose of Pl1a (Amaurobitoxin; 30 mg),
snowdrop lectin (GNA; 30 mg) or Pl1a/GNA fusion protein (Amaurobitoxin/GNA; dose as indicated). (D) Growth of 5th instar larvae after feeding a single dose of Pl1a (Amaur-
obitoxin; 30 mg), snowdrop lectin (GNA; 30 mg) or Pl1a/GNA fusion protein (Amaurobitoxin/GNA; 30 mg).
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these results are diagnostic of incorrect mol. wts. under “normal”
conditions due to residual secondary structure and interactions
between cysteine residues prior to or during electrophoresis.
The Pl1a/GNA fusion protein (Fig. 2C) contained a closely spaced
double band of an indicated size of 18 kDa, similar to the expected
molecular weight for the fusion protein (17.3 kDa); pretreatment of
samples with 6M urea caused a slight shift inmolecular weight to a
lower value, and replacement of the double band by a single band,
once again suggesting the double band was an artefact (data not
presented). The N-terminal sequence of the single band was
determined as E-A-A-A-G-, as expected for the fusion protein after
removal of the yeast a-factor prepro-region during translation and
secretion from Pichia. The fusion protein gave two further bands on
gel when analysed by SDS-PAGE. It contained a small amount of a
band at an indicated molecular weight similar to recombinant GNA
(12.7 kDa), which was immunoreactive to anti-GNA antibodies,
suggesting a small amount of cleavage of the fusion protein into its
components was occurring during production and puriﬁcation. The
ratio of intact PI1a/GNA fusion protein to cleaved GNA was esti-
mated as approx. 30:1 as judged by Coomassie blue staining on
SDS-PAGE gels. The Pl1a/GNA fusion protein also contained a
prominent band at an indicated mol. wt. of approx. 21 kDa, roughly
equal in intensity to the band assumed to be Pl1a/GNA fusion
protein. This was again immunoreactive with anti-GNA antibodies,
and had an identical N-terminal sequence to the 18 kDa band.
Treatment with the deglycosylating enzyme PNGase F, which
cleaves carbohydrate side chains attached to Asn residues through
N-glycosidic bonds, removed this band, while the intensity of the
“correct” band for the Pl1a/GNA fusion protein increased as a result
of the treatment (Fig. 2D). This result suggests that the extra band isdue to “core” glycosylation of the fusion protein by P. pastoris
during synthesis and secretion. GNA contains no potential N-
glycosylation sites, but the Pl1a toxin sequence contains a potential
N-glycosylation site (N-X-S/T) at Asn-35. Quantitation of the Pl1a/
GNA fusion protein was based on the combined intensity of both
the bands representing the glycosylated and non-glycosylated
forms. Treatment with PNGase F also removed a “smear” of mate-
rial of higher molecular weight on SDS-PAGE in Pl1a/GNA, which
was assumed to represent hyper-glycosylated fusion protein.
3.2. Toxicity of proteins to cabbage moth larvae after injection into
the haemolymph
Newly eclosed 5th instar larvae (approx. 45e55 mg in weight;
average weight 50 mg) of M. brassicae were injected with recom-
binant PI1a and PI1a/GNA fusion protein to assay biologically ac-
tivity in vivo. Larvae injected with PI1a toxin all displayed ﬂaccid
paralysis within 1e2 h (little mobility and almost a complete
absence of feeding). Most mortality was observed within the ﬁrst
24 h of the assay (Fig. 3A). After a period of paralysis, some insects
showed progressive recovery, and were able to recommence
feeding. The effects of Pl1a were dose dependent, with mortality
after 24 h ranging from 75% at 20 mg toxin/insect to 20% at 1.25 mg
toxin/insect. Even at high doses of toxin, complete mortality after
72 hwas not observed. From these assays, the estimated LD50 (48 h)
for the recombinant Pl1a was 4.1 mg/insect, or 8.2 mg/100 mg insect,
based on an average larval weight of 50 mg.
The Pl1a/GNA fusion protein also caused paralysis and mortality
when injected into M. brassicae larvae, but was signiﬁcantly more
effective than toxin alone. When insects were injected with 1.25e
10 mg fusion protein/insect (equivalent to 0.50e4.0 mg PI1a/insect,
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that of the PI1a/GNA fusion protein), signiﬁcant mortality was
observed at all doses, and complete mortality at 24 h was observed
at the highest dose (Fig. 3B). As observed for Pl1a, most mortality
occurred within the ﬁrst 24 h of the assay, and effects of PI1a/GNA
fusion protein were dose dependent, ranging from 100% mortality
at 10 mg fusion protein/insect to 33% mortality at 1.25 mg fusion
protein/insect after 24 h. Mortality at this lowest dose of fusion
protein increased to 67% after 72 h whereas mortality from injec-
tion of 1.25 mg toxin alone/insect did not change from 20% in the
period 24e72 h. From these assays, the estimated LD50 (48 h) for
the recombinant Pl1a/GNA fusion protein was 1.4 mg/insect, or
2.8 mg/100 mg insect, based on a mean larval weight of 50 mg. The
LD50 estimated for fusion protein is equivalent to 0.57 mg of re-
combinant Pl1a toxin per insect, making the fusion protein approx.
7.5 times as active as the recombinant toxin. A similar ratio is ob-
tained by using mortality ﬁgures at 72 h. Direct comparisons of
mortality produced by identical doses of toxin and fusion protein
show that the treatments are different from each other, and from
control, at p < 0.0001 (ANOVA). In all these assays, no mortality of
control injected insects was observed over 72 h.
3.3. Toxicity of proteins to cabbage moth larvae after oral delivery
Newly hatched third instar larvae ofM. brassicae could consume
up to 2 ml droplets of phosphate buffered saline (PBS) containing
10% w/v sucrose if starved for 24 h prior to the experiment. This
method was used to deliver recombinant proteins to assay their
oral toxicity, by dissolving the protein in the PBS/sucrose solution.
Two doses of PI1a/GNA fusion protein (20 mg and 30 mg per droplet)
and one dose each of Pl1a (30 mg) and GNA (30 mg) were delivered
as experimental treatments. Control larvae were fed PBS/sucrose.
Results are shown in Fig. 3C.
Effects on mortality caused by the different treatments were
observed over the ﬁrst 6 days of the assay, with no further effects
up to day 8; control survival was 100% over this period. All protein
treatments caused reduced survival, but the Pl1a toxin effect was
not signiﬁcant (survival analysis, log rank test), causing only 10%
mortality. The effect of GNA, which caused 20% mortality, was just
signiﬁcant (p ¼ 0.037). In contrast, both doses of fusion protein
caused highly signiﬁcant effects on survival (p < 0.01). A single
30 mg dose of the Pl1a/GNA fusion protein led to complete larval
mortality after 6 days, with most mortality occurring in the ﬁrst 4
days after exposure; the 20 mg dose of fusion protein caused 45%
mortality. Insects exposed to fusion protein showed partial paral-
ysis, and became lethargic and unresponsive.
Toxic effects were also observed when Pl1a/GNA fusion protein
was fed to larger larvae. Newly eclosed ﬁfth instar larvae fed a
single dose of 30 mg of PI1a/GNA fusion protein showed 35% mor-
tality over 4 days, whereas control larvae or larvae fed 30 mg doses
of PI1a or GNA exhibited 100% survival (signiﬁcantly different;
p < 0.0001). Surviving insects which had been fed the fusion pro-
tein showed strongly retarded growth, increasing their weight only
two-fold over 4 days, whereas control insects increased their
weight 8-fold (Fig. 3D). Insects, which had been fed Pl1a or GNA
showed no difference in weight gain to the control. The difference
in mean larval weight values between fusion-exposed and control,
GNA and PI1a treatments was highly signiﬁcant (P < 0:0001;
ANOVA). The effect of Pl1a/GNA fusion protein was not the same as
starvation, since insects fed no diet showed a weight loss (ﬁnal
weight: initial weight ¼ 0.57) over this period. Instead, oral
administration of the fusion protein caused reduced feeding after
administration. Insects were transferred back to standard rearing
diet, and consumption of diet was measured by decrease in wet
weight. The consumption of diet by insects was correlated withtheir weight gain; larvae fed diet containing fusion protein
consumed approx. 10% of the diet consumed by controls over 5
days, whereas consumption by larvae fed Pl1a or GNA did not differ
signiﬁcantly from controls (result not presented). The reduced diet
consumption is consistent with the observation that insects
consuming fusion protein became lethargic and unresponsive, even
after transfer back to rearing diet.
3.4. Detection of ingested PI1a/GNA in cabbage moth larval tissues
after oral delivery
To establish that the PI1a/GNA fusion protein was capable of
transporting across the gut inM. brassicae larvae, haemolymph was
extracted from insects fed on diets containing fusion protein and
was analysed for the presence of fusion protein bywestern blotting,
using anti-GNA antibodies (Fig. 4A). Insects were starved, given a
single 20 mg dose of Pl1a/GNA in liquid diet, and then returned to
normal rearing diet, so the experiment is essentially a “pulse-
chase”. The blot conﬁrmed that intact PI1a/GNA fusion protein was
present in treated insects after 2 h, whereas control insects showed
no immunoreactivematerial. Thewestern blot showed evidence for
partial proteolysis of the Pl1a/GNA fusion protein, with increased
levels of a band corresponding in size to GNA being visible on the
blots in comparison to puriﬁed fusion protein; the sample taken 4 h
after feeding the protein shows a “GNA” band comparable in in-
tensity to the fusion protein bands, whereas in the puriﬁed protein
the “GNA” band is present only at very low intensity compared to
the fusion protein bands. The time course of accumulation of fusion
protein in the haemolymph gave an unexpected result in that levels
of Pl1a/GNA in the haemolymph increased from the 2 h after
feeding sample to 4 h, but the haemolymph sample taken 6 h after
feeding contained only very small amounts of Pl1a/GNA compared
to the 4 h sample; this result was reproducible over different
feeding experiments. Samples taken at later times (24e72 h)
showed fusion protein present in haemolymph at higher levels
than at 6 h after feeding.
One destination of Pl1a/GNA fusion protein delivered to the
haemolymph was the central nervous system, the site of action of
the toxin. This was shown by dissection of nerve chords from in-
sects after feeding, and analysis by Western blotting (Fig. 4B).
Proteins extracted from nerve chords showed immunoreactivity
with anti-GNA antibodies, at a level that increased from 2 to 4 h
after feeding, and then remained similar for up to 24 h. The
immunoreactive bands indicated a higher level of intact fusion
protein than the product of proteolysis, GNA. Levels of fusion pro-
tein in the nerve chord then declined from 24 h to 72 h after
feeding. This accumulation of GNA-based neurotoxic fusion pro-
teins on the nerve chord of insects has been observed previously by
direct visualisation using labelled proteins (Fitches et al., 2012).
Further examination of tissues from insects fed a “pulse” of Pl1a/
GNA fusion protein conﬁrmed the disappearance of immunoreac-
tive bands from gut and haemolymph 6 h after feeding, and a
reappearance of the fusion protein and GNA after 24 h, ﬁrst in the
haemolymph at 24 h after feeding and then in the gut at 48 h and
72 h after feeding (Fig. 4C). These results suggest that the Pl1a/GNA
fusion protein initially binds to nervous tissue, but is subsequently
released back into the haemolymph, and subsequently reassociates
with gut tissue. In a conﬁrmatory experiment, Pl1a/GNA fusion
protein was injected into the haemolymph of M. brassicae larvae at
sub-lethal levels, and was detected in different tissues after 4 h
(Fig. 4D). Pl1a/GNA was found associated with gut tissue and
Malpighian tubules; a small of amount of protein was also present
in fat body. No evidence of proteolytic cleavage of this material to
GNA was observed, conﬁrming that haemolymph contains low
levels of proteolytic activity, in contrast to high levels of protease in
Fig. 4. Transport of Pl1a/GNA fusion protein from gut contents to haemolymph, Malpighian tubules, fat body and nerve chord in larvae of cabbage moth (Mamestra brassicae). Larvae
were injected or fed a single dose of Pl1a/GNA fusion protein, and tissues were sampled at the indicated time after feeding. The presence of Pl1a/GNA fusion protein was visualised
by SDS-PAGE analysis of extracted proteins, followed by western blotting using anti-GNA antibodies. (A) Haemolymph from treated and control insects after feeding Pl1a/GNA. (B)
Nerve chords from treated and control insects after feeding Pl1a/GNA. (C) Gut and haemolymph 2 h, 4 h, 6 h, 20 h, 24 h and 48 h, respectively, after feeding Pl1a/GNA; ha,
haemolymph; g, gut. (D) Various tissues 4 h after injection of Pl1a/GNA to hemolymph.
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when Pl1a/GNA was delivered orally (Fig. 4A).3.5. Effects of Pl1a and Pl1a/GNA fusion protein on houseﬂy
Bioassays using houseﬂy were carried out on adult insects,
which could be injected using basic equipment without causing
high levels of mortality. These assays showed that both the re-
combinant Pl1a toxin and the Pl1a/GNA fusion protein caused pa-
ralysis and mortality when injected. Typical results are shown in
Fig. 5A and B. Mortality was dose dependent, with most insect
deaths taking place in the ﬁrst 72 h after injection. A dose of 1.0 mg
of recombinant Pl1a caused 100% mortality in 72 h, and doses
0.5 mg caused 100% mortality in 144 h The data gave an estimated
LD50 (72 h) of 0.18 mg Pl1a per insect, or approx. 1.8 mg Pl1a per
100 mg insect, based on an average adult weight of approx. 10 mg.
The Pl1a/GNA fusion protein was signiﬁcantly more effective than
the recombinant toxin, withmore rapidmortality at lower doses; at
a dose of 0.24 mg per insect, 100%mortality was observed after 24 h.
The estimated LD50 (72 h) for the fusion protein was 0.045 mg per
insect, or approx. 0.45 mg fusion protein per 100 mg insect; this is
equivalent to 0.18 mg of Pl1a, making the fusion protein approx. 10times as effective, on a mole-for-mole basis, as the recombinant
toxin. The Pl1a/GNA fusion proteinwas also an effective toxinwhen
fed to adult M. domestica (Fig. 5C); a 0.25 mg/ml solution caused
100% mortality in 72 h, whereas 0.125 mg/ml solution caused 70%
mortality. Flies were completely paralysed approx. 2 h after
feeding, and most paralysed insects subsequently died. Higher
concentrations of the fusion protein caused lower mortality over 6
days, as the insects would not feed, or fed only very little; the
chambers were moist enough to allow insects to survive without
feeding.
Attempts to inject larvae of M. domestica also showed that both
the toxin Pl1a and the Pl1a/GNA fusion protein were effective
toxins, but control survival in these assays was erratic due to
damage from the injection. Larvae could not be induced to feed on
material containing recombinant proteins.3.6. Effects of oral delivery of Pl1a/GNA fusion protein on pea aphids
Puriﬁed recombinant PI1a, Pl1a/GNA fusion protein and re-
combinant GNAwere fed to A. pisum nymphs by incorporation into
artiﬁcial diet at a range of concentrations (Fig. 6A). Survival and
growth of the insects weremonitored. Aphids feeding on 1.0 mg/ml
Fig. 5. Bioassays of Pl1a and Pl1a/GNA against adults of houseﬂy (Musca domestica). (A) Survival of adult ﬂies after injection of varying amounts of Pl1a toxin. (B) Survival of adult
ﬂies after injection of varying amounts of Pl1a/GNA fusion protein. (C) Survival of adult ﬂies allowed to feed ad libitum on solutions containing Pl1a/GNA fusion protein
(Amaurobitoxin/GNA; concentration as indicated).
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feeding, which was signiﬁcantly different to negative controls,
whereas aphids feeding on diet containing 0.24 mg/ml Pl1a or
0.76 mg/ml GNA showed only 53.3% or 33.3% mortality in 7 days of
feeding compared with 1.0 mg/ml Pl1a/GNA. Moreover, feeding a
mixture of Pl1a (0.24 mg/ml) and GNA (0.76 mg/ml), which was
equivalent to 1 mg/ml Pl1a/GNA fusion protein in the content,
showed 83.3% mortality in 7 days of feeding whereas 1 mg/ml Pl1a/
GNA caused 100% mortality in 3 days. The fusion protein survival
curve was signiﬁcantly different to controls and other treatments
(p < 0.001). The treatments also decreased in aphid growth by
approx. 60%, which was signiﬁcant compared to controls, but dif-
ferences between treatments were not signiﬁcant (data not
presented).
Feeding Pl1a/GNA at different concentrations from 0.25 mg/ml
to 1 mg/ml showed a dose dependent effect on A. pisum survival
(data not presented). After 7 days of feeding, 1.0 mg/ml Pl1a/GNA
caused 100% mortality whereas the lowest concentration of Pl1a/
GNA, 0.25 mg/ml, produced approx. 10% mortality. From 0.5 mg/ml
to 1 mg/ml, all survival curves for Pl1a/GNA were signiﬁcantly
different to negative controls, and aphid growth was signiﬁcantly
reduced. However, the size of 0.25 mg/ml Pl1a/GNA-fed aphids was
not signiﬁcantly different to control aphids, suggesting that the
aphids were capable of overcoming the growth retardation effects
of 0.25 mg/ml Pl1a/GNA.
To demonstrate binding of proteins to the aphid gut surface,
recombinant Pl1a, GNA and Pl1a/GNA fusion protein were labelled
by conjugation with ﬂuorescein, and fed in diet to aphids at a sub-
lethal concentration (0.8 mg/ml Pl1a, 1 mg/ml GNA and 0.64 mg/ml
Pl1a/GNA) for 24 h. The label was then ‘‘chased’’ by allowing aphids
to feed on control diet for 24 h and 48 h. Labelled proteins were
detected in whole insects by ﬂuorescence microscopy, and were
readily detectable in insects with no chase after feeding. Results arepresented in Fig. 6B. Fluorescein, used as a negative control, (Fig. 6B,
panel 24), was eliminated completely from the aphid gut after 48 h
chase, whereas ﬂuorescein-labelled GNA, used as a positive control,
was still present in the gut after 48 h chase (Fig. 6B, panel 12). As
expected, the labelled Pl1a/GNA fusion protein also persisted in the
midgut region of aphids, and was detectable even after 48 h chase
(Fig. 6B, panel 6). Surprisingly, labelled recombinant Pl1a could also
bind to the gut (Fig. 6B, panels 16e17), and was detectable after
24 h chase, although the level of binding after 48 h chase decreased
to undetectable, (Fig. 6B panel 18), in contrast to labelled GNA and
Pl1a/GNA, which were detectable after 48 h chase. These results
showed that although recombinant Pl1a, GNA, and Pl1a/GNA could
all bind to the aphid gut, recombinant Pl1a was most readily
removed, suggesting weaker binding.4. Discussion
The d-amaurobitoxin PI1a was selected as a possible component
for biopesticidal fusion proteins for reasons described earlier
(insecticidal activity and insect-speciﬁcity), but also because it is
effective against a different target than previous insecticidal neu-
rotoxins used in lectin-based fusion proteins; Sﬂ1, from the spider
Segestria ﬂorentina (Fitches et al., 2004) has an unknown target,
ButaIT from the scorpionMesobuthus tamulus (Trung et al., 2006) is
assumed to target chloride channels, and Hv1a, from the spider
Hadronyche versuta (Fitches et al., 2012) targets calcium channels.
As a toxin which targets the insect sodium channel (Corzo et al.,
2005), Pl1a therefore represents a novel type of insecticidal
component. The insect sodium channel is a major target for con-
ventional pesticides, such as pyrethroids, and inactivation leads to
rapid paralysis and death; exploitation of this target in the insect is
thus based on established practice.
Fig. 6. Bioassays of Pl1a and Pl1a/GNA against nymphs of pea aphid (Acyrthosiphon pisum). (A) Survival of aphids on diets containing Pl1a (Amaurobitoxin), snowdrop lectin (GNA)
or Pl1a/GNA fusion protein (Amaurobitoxin/GNA) at concentrations as indicated. (B) Feed-chase experiment to show binding of proteins to aphid gut. Diets containing recombinant
proteins labelled with FITC were fed to aphids for 24 h. Subsequently the label was “chased” with control diet for times as indicated. Red ﬂuorescence indicates the aphid gut, green
ﬂuorescence indicates labelled proteins. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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toxin (Ferrat et al., 2005). Although most spider toxins just slow
NaCh inactivation in a fashion similar to that of receptor site 3
modiﬁers, d-amaurobitoxins are similar to scorpion b-toxins in
binding with high afﬁnity to the topologically distinct receptor site
4, which involves domain II in insect and mammalian NaChs
(Cestele et al., 1998). d-amaurobitoxins and scorpion b-toxins show
some similarity in their bioactive surfaces and ability to compete
for an identical receptor (site 4) on voltage-gated NaChs, though
they have developed from different ancestors. The d-amaur-
obitoxins like PI1a recognize insect voltage-gated sodium channels
by multiple sequence features, including a b-sheet secondary
structure, loops I, IV of the toxin and the speciﬁc dipolar moment
orientation (Ferrat et al., 2005). The roles of different amino acid
residues in determining binding and toxicity have been investi-
gated by alanine scanning mutagenesis; Asp-19 may be causal in
toxicity, since substitution of this residue by Ala affected toxicity to
lepidopteran larvae, but not binding to the sodium channel (Corzo
et al., 2005). These results can be exploited to manipulate the toxin
component of a fusion protein if necessary to modify activity or
speciﬁcity. Data for the insecticidal activity of Pl1a (Arachnoserver)
suggests that it shows a higher LD50 on a mole/g basis than than
that reported for Hv1a, the toxin component of the atracotoxin/
GNA fusion protein described by Fitches et al. (2012).The yeast Pichia pastoris was selected as expression host for
production of recombinant PI1a and Pl1a/GNA fusion proteins on
the basis of previous work showing that small proteins containing
multiple disulphide bonds can be produced in active form in this
organism (Cereghino and Cregg, 2000). Efﬁcient secretion of
expressed proteins into the culture medium, directed by the yeast
a-factor prepro-sequence incorporated into the expression vector
pGAPZa, is an additional advantage in that puriﬁcation of the re-
combinant protein is simpliﬁed by having relatively few contami-
nating Pichia proteins present in the culture medium, and not
having to lyse cells to obtain the product. Proteolysis of fusion
proteins produced in P. pastoris during secretion, or in the culture
medium, or during puriﬁcation, has been a signiﬁcant problem
with previous toxin-GNA fusions (Fitches et al., 2004), resulting in
the ﬁnal product containing signiﬁcant amounts (up to 50%) of GNA
without attached toxin. However, the Pl1a/GNA fusion protein is
relatively resistant to proteolysis, and the puriﬁed product contains
only small amounts of free GNA.
P. pastoris has an efﬁcient N-glycosylation system for proteins
which pass through the ER, although in most cases core glycosyl-
ationwith a branched oligomannose structure is only elaborated by
addition of extra mannose residues (Bretthauer and Castellino,
1999). Both the recombinant Pl1a toxin and the Pl1a/GNA fusion
protein contain an N-glycosylation site, corresponding to the
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only the fusion protein shows evidence of glycosylation at this site.
Utilisation of an N-glycosylation site requires the amino acid resi-
dues to be accessible to the glycosylating enzyme(s), and not all
sites are used. The difference in glycosylation properties of the re-
combinant toxin and fusion protein is evidence for differences in
folding and accessibility in this region of the toxin.
Both the recombinant toxin alone and the fusion protein, show
insecticidal activity on injection into lepidopteran and dipteran
insects, with the expected symptoms of paralysis and mortality.
However, in both sets of assays, the fusion protein has an activity at
least 6-fold higher on a molar basis than the recombinant toxin.
There is some evidence from injection bioassays to suggest that the
recombinant toxin has lower insecticidal activity than expected.
The LD50 for recombinant toxin alone observed in the injection
bioassays against M. brassicae larvae, 4.1 mg/insect, or 12 nmoles/g
insect is approx. 5-fold higher than the quoted literature value for
puriﬁed and synthetic Pl1a toxins of 2.35 nmoles/g insect for larvae
of S. litura [LD50 (48 h) ¼ 9.5 mg/g insect; Corzo et al., 2000]. In
contrast, the LD50 for the recombinant fusion protein is lower than
this literature value for puriﬁed toxin when expressed on a molar
basis; 1.4 mg/insect for Pl1a/GNA is equivalent to 1.6 nmoles/g in-
sect. If it is assumed that larvae of the two lepidopteran species
have similar susceptibility to the Pl1a, then these data would sug-
gest that the toxin in the Pl1a/GNA fusion protein has the expected
biological activity, whereas the recombinant toxin alone does not.
Two possibilities can be advanced to explain this observation. First,
fusion to GNA could improve toxin folding during production as a
recombinant protein, leading to a product with more biological
activity. Secondly, the carbohydrate-binding activity of GNA en-
ables it to act as an anchor to bind toxin to nerve tissue and increase
its local concentration, leading to a higher effective dose. The evi-
dence from western blotting showing high levels of fusion protein
associated with nerve chord tissue supports this hypothesis. The
results presented here, in agreement with previous data (Fitches
et al., 2012), show that fusion to GNA can enhance recombinant
toxin biological activity.
The droplet feeding assays provide clear evidence of the oral
toxicity of the Pl1a/GNA fusion protein towards lepidopteran and
dipteran insects. In the assays with M. brassicae larvae no signiﬁ-
cant toxicity of the toxin alone was observed, and only marginal
effects from the GNA carrier, in agreement with previous assays in
which GNA was fed to larvae of tomato moth, Lacanobia oleracea
(Fitches et al., 2001). Only the fusion protein was tested against
M. domestica adults, but previous results have shown that GNA
alone has only limited toxicity at high doses (Fitches et al., 2009).
The resistance to proteolysis shown by the Pl1a/GNA fusion protein,
observed during production and puriﬁcation, is likely to be a factor
in its oral toxicity; a high proportion of the GNA transported across
the gut will be fused to the toxin, resulting in efﬁcient transport of
toxin into the haemolymph (free toxin does not transport, since
orally delivered toxin is ineffective). However, some cleavage of
fusion protein to release GNA does occur in the larval gut, since
signiﬁcant levels of free GNA are subsequently present in the
haemolymph, and fusion protein injected into the haemolymph is
stable. High levels of proteolytic activity are present in the larval
gut of M. brassicae (Chougule et al., 2008).
The western blotting experiments show transport of intact
fusion protein into the haemolymph, and accumulation on nervous
tissue; after feeding a single dose, fusion protein initially accumu-
lates in the haemolymph, and then clears after 6 h. The subsequent
reappearance of fusion protein in haemolymph after 24 h is most
likely to be due to release from nervous tissue that is being
degraded, as a result of partial or complete inactivation due to the
toxin. Although the initial transport of fusion protein is from gut tohaemolymph, interestingly, retrograde transport of fusion protein
from haemolymph to gut can also occur, suggesting that transport
across the gut is a passive, rather than an active process.
Whereas the Pl1a/GNA fusion protein shows effective oral
toxicity in the lepidopteran and dipteran insects tested while its
component proteins either have no toxicity, or very limited toxicity,
the situation is less clear cut in aphids. The fusion protein was a
more effective toxin than either of its components, or a mixture of
its components, but both components of the fusion showed sig-
niﬁcant oral toxicity. For GNA, this is in agreement with previous
reports of oral toxicity to aphids and other hemipteran insects. The
oral toxicity of the Pl1a toxin itself is more surprising, and the
mechanism through which the toxin is able to access sites of action
when fed to aphids remains obscure. Further experiments will be
necessary to show whether the binding of toxin to the gut surface
in aphids leads to transport to the haemolymph (as is the case for
GNA) or whether the toxin remains in the gut contents. In this
example, fusion to GNA enhances the oral toxicity of Pl1a rather
than conferring novel oral toxicity.
The amaurobitoxin-lectin fusion protein described in this paper
is a promising candidate for development as a biopesticide with
activity against lepidopteran and dipteran pests; it has an approx.
10-fold lower LD50 towardsM. brassicae larvae by injection than the
Hv1a/GNA fusion protein described by Fitches et al. (2012), and
caused mortality after droplet feeding a single dose to 5th instar
larvae of M. brassicae, whereas a greater dose of Hv1a/GNA fusion
protein only caused growth retardation. It is also approx. 8-fold
more active towards M domestica adults than the ButaIT/GNA
scorpion toxin fusion protein described by Fitches et al. (2009),
where a 1.0 mg/ml solution caused only 75% mortality after 72 h, in
contrast to 70%mortality produced by a 0.125 mg/ml solution of Pl1a/
GNA. Further trials of insecticidal activity and selectivity will be
necessary to ensure that the fusion protein could be used safely in
agricultural applications.
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